|
| Stages of development | |||||||
| Treatments | 2˚ instar | 3˚ instar | 4˚ instar | 5˚ instar | Total | |||
| Bt | 3.07 ± 0.15a | 4.47 ± 0.29a | 4.60 ± 0.35a | 6.74 ± 0.41a | 18.68 ± 0.99 a | |||
| Conventional | 3.23 ± 0.13a | 3.83 ± 0.20a | 4.92 ± 0.30a | 7.11 ± 0.43a | 19.61 ± 0.64 a | |||
| CV(%) | 11.62 | 15.98 | 17.64 | 13.76 | 9.82 | |||
|
| Nymphal viability (%) | |||||||
| Treatments | 2˚ instar | 3˚ instar | 4˚ instar | 5˚ instar | ||||
| Bt | 100a | 100a | 83.3a | 63.3a | ||||
| Conventional | 100a | 100a | 86.6a | 60.0a | ||||